Latest topics page 23

Second pass at: The topic list is dense — is that deliberate? I have a specific reason for asking rather than idle curiosity, and the context is below. Posting a small dataset on topic list. It is mine, it is…

On the subject in the title: Availability by country, dated, with primary sources Working notes rather than a conclusion. Documenting an access outcome, dated, because everything in this category expires. As…

On the subject in the title: Levothyroxine timing: a real interaction with a simple fix Working notes rather than a conclusion. A follow-up question about Levothyroxine timing that I did not know to ask the…

Rewriting my first post: a before-and-after, with commentary Writing it up because I had to work it out twice and would rather nobody else did. I want to check my reasoning rather than get a conclusion. My…

Cost per delivered dose, which is the number that matters — setting out what I have, and where I think it stops being reliable. Documenting an access outcome, dated, because everything in this category…

Adsorptive losses at low concentration, and why dilute solutions are fragile — setting out what I have, and where I think it stops being reliable. Collecting what is known about adsorptive losses in one…

IGF-1 as a surrogate endpoint and its limitations Writing it up because I had to work it out twice and would rather nobody else did. IGF-1, and specifically the version of it that the documentation does not…

On the subject in the title: Distinguishing expected GI effects from something that needs urgent attention Working notes rather than a conclusion. Reporting something rather than asking about it, in case the…

On the subject in the title: Reading an interaction checker output critically Working notes rather than a conclusion. A question about reading an interaction checker output that I think has a definite answer,…

On the subject in the title: Dizziness on standing and the electrolyte explanation Working notes rather than a conclusion. Trying to work out what would count as evidence on dizziness on standing, before…

Which fields on a certificate actually matter, ranked — that is the question, and I have not found it answered plainly anywhere I have looked. I would like to understand what this number means before I repeat…

The question in the title: Why semaglutide solutions can look faintly opalescent and when that matters I will give what I have already checked below so nobody repeats it. A follow-up question about…

Nausea profile of amylin analogues compared with GLP-1 agonists Writing it up because I had to work it out twice and would rather nobody else did. I have spent a fortnight trying to pin nausea profile of…

Warfarin and altered intake: the monitoring argument — setting out what I have, and where I think it stops being reliable. Proposing that warfarin and altered intake deserves a maintained page rather than a…

On the subject in the title: A staff appointment, and what the role involves Working notes rather than a conclusion. Asking about staff appointment on behalf of the question I keep seeing asked badly,…

Posting this under the heading it deserves: Introducing myself: pharmacist, sceptic, reluctant participant — one year on Everything below is what sits behind that. Introducing myself before I ask anything,…

Posting this under the heading it deserves: Warfarin and altered intake: the monitoring argument — the long version Everything below is what sits behind that. A narrow question about Warfarin and altered…

Second pass at: Circumference measurements as a poor man's composition estimate — setting out what I have, and where I think it stops being reliable. Two things I would like separated before anyone answers on…

Semaglutide half-life: where the 165 to 184 hour figure comes from — setting out what I have, and where I think it stops being reliable. Putting the numbers in the first post, because a question about a…

Oral versus injected administration claims for BPC-157 — setting out what I have, and where I think it stops being reliable. I have spent a fortnight trying to pin oral versus injected administration claims…

Revisiting: Maintainer handover: how it works Writing it up because I had to work it out twice and would rather nobody else did. Maintainer handover keeps being re-asked here and I think that is because the…

Posting this under the heading it deserves: Revisiting: Reading order for a first week here, and what to skip until later Everything below is what sits behind that. Trying to work out what would count as…

On the subject in the title: Angle of injection and whether 90 degrees is always right Working notes rather than a conclusion. Something about angle of injection does not reconcile and I would like a second…

Posting this under the heading it deserves: Whether protein timing matters at a large deficit Everything below is what sits behind that. A follow-up question about whether protein timing that I did not know…

On the subject in the title: Reconciling a label claim with a content assay Working notes rather than a conclusion. The question about reconciling a label claim that I actually want answered is the second one…

Second pass at: What to keep a record of at the point of payment — setting out what I have, and where I think it stops being reliable. A payments question, with the mechanics separated from the money. What I…

Reading a preclinical wound-healing model and its relevance to a human tendon — a second dataset — setting out what I have, and where I think it stops being reliable. Posting a small dataset on Reading a…

Posting this under the heading it deserves: Realistic expectations for strength while losing weight quickly Everything below is what sits behind that. Working notes on realistic expectations for strength…

Splitting a weekly dose in two: the pharmacokinetic argument against — setting out what I have, and where I think it stops being reliable. I have read the maintained page on this and I still have a gap, so I…

The question in the title: How the published trials escalated, tabulated side by side I will give what I have already checked below so nobody repeats it. Something about published trials escalated does not…